Crown Bioscience investeert in uitmuntende processen met de benoeming van een nieuwe vice-president van Global Quality
SAN DIEGO– (BUSINESS WIRE) – Crown Bioscience kondigt vandaag de benoeming aan van Pam Shang als vice-president voor wereldwijde kwaliteit. Mevrouw Shang zal een belangrijke rol spelen bij het verder verbeteren van de wereldwijde kwaliteit in het hele bedrijf, door gebruik te maken van haar diepgaande expertise in het implementeren van kwaliteitssystemen voor farmaceutische en biotechnologische klanten, waaronder in GLP, GMP en andere gereguleerde omgevingen.
Voortbouwend op CrownBio’s bestaande platforms, zal mevrouw Shang verantwoordelijk zijn voor de strategische richting, verbetering en groei van CrownBio’s kwaliteitssystemen, onderliggende organisatieprocessen en het leiden van het bijbehorende verandermanagement.
“Ik ben verheugd Pam te verwelkomen in het leiderschapsteam”, zegt Armin Spura, PhD, CEO van CrownBio. “Met haar schat aan ervaring in het implementeren van wereldwijde kwaliteitssystemen en het overzien van GxP-initiatieven, zal Pam ervoor zorgen dat CrownBio kwaliteit en onze klanten voorop stelt bij alle CrownBio-initiatieven”.
Crown Bioscience Invests in Process Excellence with the Appointment of New Vice President of Global Quality
SAN DIEGO–(BUSINESS WIRE)– Crown Bioscience today announces the appointment of Pam Shang as vice president for global quality. Mrs. Shang will be instrumental in further enhancing global quality across the company, leveraging her deep expertise in implementing quality systems for pharma and biotechnology clients including in GLP, GMP and other regulated environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201008005432/en/
Pam Shang, CrownBio Vice President of Global Quality (Photo: Business Wire)
Building on CrownBio’s existing platforms, Mrs. Shang will be responsible for the strategic direction, enhancement, and growth of CrownBio’s quality systems, underlying organizational processes, and leading the associated change management.
“I am excited to welcome Pam to the leadership team,” said Armin Spura, PhD, chief executive officer of CrownBio. “With her wealth of experience in implementing global quality systems and overseeing GxP initiatives, Pam will ensure that CrownBio puts quality and our customers at the forefront of all CrownBio initiatives”.
Mrs. Shang joins CrownBio from Asahi Kasei America, a Japanese pharmaceutical company, where she was head of global quality and compliance. Pam was responsible for all regulatory matters across diverse areas including quality oversight and control, regulatory compliance, and audit management.
CrownBio has seen consistent quality improvements year-on-year, with associated enhanced client satisfaction. The new strategic initiatives led by Mrs. Shang across global operational platforms will ensure high scientific quality and a continued dedication to enhance standards and performance across the company.
“I’m delighted to bring my expertise to CrownBio”, said Pam Shang. “The quality of our work and compliance to regulatory standards is extremely important, and pivotal for CrownBio’s continued growth. My aim is to ensure that all staff are empowered with proper resources and regulatory knowledge to be successful and accountable, to foster a success-oriented, safe working environment and to ensure the scientific quality of our products and services”.
Mrs. Shang holds a BS in Management Information Systems and a minor in Business from Southern Illinois University. She also completed Master’s Program course requirements in Biotechnology at Harvard University.
About Crown Bioscience Inc.
Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology, inflammation, and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates. For more information, visit:
View source version on businesswire.com: https://www.businesswire.com/news/home/20201008005432/en/
Contacts
Media Enquiries:
Jody Barbeau
Crown Bioscience Inc.